So, how does it work? Well, apparently a person’s voice changes in certain ways when there is a heart issue. But the change is too subtle for the person, or anyone else, to notice. But the new tech from Cardion Medical, the HearO, can detect this.
Founded in 2013, Cordio Medical develops and provides solutions for monitoring health conditions through a patient’s voice. A patient’s free speech into a smartphone app allows near real-time monitoring and early detection of condition deterioration. Cordio technologies are based on true speech signal processing technology, unique to each patient, augmented with machine learning capabilities. The system is patient-tailored, and is constantly learning the patient’s voice and providing personalized, seamless and effortless monitoring.
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at email@example.com.
Cardio Medical says that the HearO can sense fluid accumulation related to CHF and alert prior to hospitalization. The HearO, boasts the company, is the first easy to use, non-invasive, medical grade CHF monitoring device.
A person’s voice is captured by the smartphone app/voice-based digital assistance and sent for analysis by HearO. A real-time speech/voice analysis workflow detects early buildup of fluids in the patient’s lungs before the appearance of clinical symptoms. Notices are generated once a deviation from the patient pre-defined baseline.
Cardio Medical was one of nine Israeli startups to be awarded a grant by the Israel-U.S. Binational Industrial Research and Development (BIRD) Foundation this past January.
The BIRD Foundation promotes collaborations between U.S. and Israeli companies in various technological sectors for joint product development. In addition to providing conditional grants of up to $1 million (up to $1.5m for exceptional projects), the Foundation assists by working with companies to identify potential strategic partners and facilitate introductions.